Storys zum Thema Medizin, Gesundheit

Technische Universität München

Animal health through genomics | Feasibility study: Preventing diseases through genome analysis and genome scissors

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36757/ High resolution images: https://mediatum.ub.tum.de/1615373 Animal health through genomics Feasibility study: Preventing diseases ...

Technische Universität München

In many cases, MS starts long before the diagnosis

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36707/ Picture: https://mediatum.ub.tum.de/1615270 NEWS RELEASE In many cases, MS starts long before the diagnosis Multiple sclerosis is often diagnosed years after the first symptoms appear Years before they ...

pA Medien GmbH

M3 Invests in Physicians Career Portal praktischArzt

NOMOS Glashütte/SA Roland Schwertner KG

3

Watches that help those who help

Messe Erfurt

AM plays to its strengths in the medical field

Lindera GmbH

Intelligent algorithms for movement apps: with LTech, the Lindera Software Development Kit, Berlin-based health tech company Lindera brings innovation and AI technology to the fitness industry

Sysmex Inostics GmbH

Sysmex Inostics presents data at ASCO

Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...

DAAD

DAAD Annual Report 2020: Lively exchange in difficult times

European Patent Office (EPO)

European Inventor Award 2021: Meet some of today’s most inspiring innovators at digital event on 17 June

Circular Valley

Circular Valley selects 15 start-ups from a field of international applicants for EU Green Deal

BrainRepair UG

Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M

Technische Universität München

New AI technology protects privacy in medical diagnostics

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36689/ Highresolution pictures: https://mediatum.ub.tum.de/1612604 NEWS RELEASE New AI technology protects privacy Medical diagnostics algorithm identifies pneumonia in paediatric x-ray images AI algorithms can ...

news aktuell GmbH

2

BLOGPOST: Loneliness working from home: How the pandemic has changed communication

nal von minden GmbH

Did my vaccine work? New rapid test for the determination of vaccination success

Technische Universität München

Neutrons show a connection between depression and lithium concentration in the brain

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36683/ High resolution images: https://mediatum.ub.tum.de/1612340 NEWS RELEASE Making the gray cells happy Neutrons show a connection between depression and ...

Flughafen Wien AG

EANS-News: Covid-19 Crisis Continues to Massively Burden the Aviation Sector: Flughafen Wien Group Handles 88.7% Fewer Passengers, Revenue Decline of 64.4%

issuer: Flughafen Wien AG Postfach 1 A-1300 Wien-Flughafen phone: +43 1 7007 - 23126 FAX: +43 1 7007 - 23806 mail: investor-relations@viennaairport.com WWW: http://viennaairport.com/unternehmen/investor_relations ISIN: AT00000VIE62 indexes: stockmarkets: Wien language: ...

Fluxergy

Fluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test

SCHLUMBOHM Medizin-Labor-Technologie GmbH

2

Worldwide sales of the new steam sterilizers and washer disinfectors from SCHLUMBOHM Medizin-Labor-Technologie GmbH to clinics, doctor's offices and laboratories.

Bokela GmbH

3

A Hands-On Job in China – Done Remotely

IEVA (Independent European Vape Alliance)

EU scientific committee ignores the science on vaping

Brussels (ots) - The European Commission has today missed an opportunity to bolster its Beating Cancer Plan and recognise the importance of vaping in reducing smoking-related diseases among Europeans. A report from the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)[1] has failed to compare the risks of electronic cigarette use with the risks of smoking. Such an omission renders the report of ...

Technische Universität München

Four ERC Advanced Grants for TUM scientists

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36588/ NEWS RELEASE EU funding for cutting-edge research Four ERC Advanced Grants for TUM scientists Artificial viruses made with DNA. The human lung as a computer model. A new approach to research on diseases ...

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Fluxergy

Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry

Sysmex Inostics GmbH

Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients

Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...